Assessing bleeding in von Willebrand disease with bleeding score
- PMID: 16774804
- DOI: 10.1016/j.blre.2006.04.002
Assessing bleeding in von Willebrand disease with bleeding score
Abstract
Quantification of the bleeding severity in von Willebrand disease (VWD) by use of a bleeding score (BS) could be a useful tool toward a more objective diagnosis. The BS is computed as the sum of arbitrary grades of bleeding severity for several hemorrhagic symptoms, and in normal subjects is nearly always lower than 3. In the diagnosis of type 1 VWD, the use of the BS provided a high specificity (99.1%) and a satisfactory sensitivity (64.2%) in a multicenter, retrospective study. The BS is strongly related to all available measurements of von Willebrand factor activity, including the PFA-100 closure time. The BS could be used to assess the influence on bleeding symptoms of other biological factors in VWD. Therefore, BS represent a promising clinical tool for the analysis of bleeding in VWD, although further validation is warranted before an extensive use in clinical practice could be purported.
Similar articles
-
Bleeding scores in inherited bleeding disorders: clinical or research tools?Haemophilia. 2008 May;14(3):415-22. doi: 10.1111/j.1365-2516.2007.01648.x. Epub 2008 Jan 21. Haemophilia. 2008. PMID: 18218013 Review.
-
The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.Br J Haematol. 2010 Nov;151(3):245-51. doi: 10.1111/j.1365-2141.2010.08333.x. Epub 2010 Aug 25. Br J Haematol. 2010. PMID: 20738304
-
Clinical diagnosis of von Willebrand disease.Haemophilia. 2004 Oct;10 Suppl 4:169-76. doi: 10.1111/j.1365-2516.2004.00991.x. Haemophilia. 2004. PMID: 15479393 Review.
-
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Haemophilia. 2008 Mar;14(2):171-232. doi: 10.1111/j.1365-2516.2007.01643.x. Haemophilia. 2008. PMID: 18315614
-
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Cited by
-
Inflammatory Biomarkers in Postural Orthostatic Tachycardia Syndrome with Elevated G-Protein-Coupled Receptor Autoantibodies.J Clin Med. 2021 Feb 6;10(4):623. doi: 10.3390/jcm10040623. J Clin Med. 2021. PMID: 33562074 Free PMC article.
-
Critical von Willebrand factor A1 domain residues influence type VI collagen binding.J Thromb Haemost. 2012 Jul;10(7):1417-24. doi: 10.1111/j.1538-7836.2012.04746.x. J Thromb Haemost. 2012. PMID: 22507569 Free PMC article.
-
Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.Mol Cell Biochem. 2010 Jul;340(1-2):249-56. doi: 10.1007/s11010-010-0424-7. Epub 2010 Mar 25. Mol Cell Biochem. 2010. PMID: 20336352
-
Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.Blood. 2017 Nov 23;130(21):2344-2353. doi: 10.1182/blood-2017-05-786699. Epub 2017 Sep 15. Blood. 2017. PMID: 28916584 Free PMC article. Clinical Trial.
-
Utility of a Paediatric Bleeding Questionnaire as a screening tool for von Willebrand disease in apparently healthy children.Haemophilia. 2015 Nov;21(6):806-11. doi: 10.1111/hae.12689. Epub 2015 May 16. Haemophilia. 2015. PMID: 25982122 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical